Your prediction
Novozymes A/S B Stock
We can see a decrease in the price for Novozymes A/S B. Compared to yesterday it has lost -€0.660 (-1.280%).
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | -1.280% | -1.393% | 9.075% | -3.813% | -6.939% | 12.669% | -8.312% |
| Solvay S.A. A | 2.830% | 5.904% | 10.963% | -5.154% | 3.734% | -72.671% | -73.415% |
| FMC Corp. | -0.140% | -3.347% | 24.435% | -54.048% | 27.148% | -86.116% | -84.189% |
| Henkel AG & Co. KGaA VZO | -0.830% | 2.393% | -8.297% | -1.824% | -4.410% | -10.341% | -32.374% |
